Micron has assembled a team of scientists and engineers with  medical device, biopharmaceutical, analytical, quality, and cGMP manufacturing experience who work in state-of-the art facilities that include wet laboratory and cleanroom space. Micron works with a network of consultants and CROs to define and execute regulatory strategies, including preclinical and clinical studies.

Micron’s capabilities include:

  • Formulation, process, and product development

  • Microneedle patch and packaging design, prototyping, testing

  • Analytical methods

  • Pre-clinical testing

  • cGMP manufacturing of clinical trial materials

  • Preclinical and clinical study design support

  • Regulatory strategy and filing

Micron develops pharmaceutical products, based on its microneedle patch technology, that are designed to provide enhanced protective (vaccine) and therapeutic (drugs) effects, superior patient compliance, and simplified administration, distribution, and storage logistics.


Phase 1 clinical trial shows safety and immunogenicity of microneedle patch for flu vaccination for the first time

(GLOBE NEWSWIRE) — Using microneedle patch technology under development at Micron Biomedical, Inc. (Micron), a Phase 1 clinical trial showed that vaccination by microneedle patch was as safe and at least as immunogenic as vaccination with standard needle and syringe. The trial was carried out by the Georgia Institute of Technology (Georgia Tech) and the…

Micron to collaborate with Georgia Tech and CDC on measles-rubella project funded by UNICEF

ATLANTA, June 19, 2017 – UNICEF awards funding to support to work of Micron Biomedical, Inc. to develop cGMP manufacturing for a measles-rubella (MR) vaccine microneedle patch, to design and support pre-clinical studies, and to develop the regulatory strategy, including IND preparation, to support a future Phase 1/2a clinical trial and, ultimately, to obtain licensure…

Micron invited to participate in the BIO 2017 conference Innovation Zone

ATLANTA, April 12, 2017 – Micron Biomedical, Inc. was selected by NIH to participate in the BIO 2017 conference in San Diego, CA, June 19-22, 2017 and to exhibit in the Innovation Zone, an exhibit space dedicated to showcasing a small number of NIH SBIR/STTR awardees.  Micron was also selected to give a presentation on…